CERo Therapeutics Inc. (CERO)
NASDAQ: CERO
· Real-Time Price · USD
5.92
-1.01 (-14.57%)
At close: Sep 05, 2025, 3:59 PM
5.69
-3.89%
After-hours: Sep 05, 2025, 07:57 PM EDT
-14.57% (1D)
| Bid | 5.9 |
| Market Cap | 7.14M |
| Revenue (ttm) | 1.16M |
| Net Income (ttm) | -13.51M |
| EPS (ttm) | -484.68 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.09 |
| Analyst | Buy |
| Ask | 6.08 |
| Volume | 4,665,357 |
| Avg. Volume (20D) | 1,119,666 |
| Open | 6.40 |
| Previous Close | 6.93 |
| Day's Range | 5.41 - 6.70 |
| 52-Week Range | 5.41 - 896.00 |
| Beta | 0.50 |
About CERO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CERO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CERO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+188.65%
CERo Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
+38.84%
CERo Therapeutics Holdings shares are trading higher after the company announced the key clinical trial site location for its Phase 1 CER-1236 trial.
